Antitrust - STAT

Pharmalot By Ed Silverman

Johnson & Johnson is fined $30 million for thwarting generics in France

Pharmalot By Ed Silverman

FTC probes Mylan for possible antitrust violations involving EpiPen

Pharmalot By Ed Silverman

Drug makers are sued for scheming to illegally fix insulin prices

Pharmalot By Ed Silverman

Two former pharma execs first to be charged in generic price-fixing probe

Pharmalot By Ed Silverman

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

Pharmalot By Ed Silverman

Lawmakers call for FTC probe into potential antitrust violations in EpiPen school program

Pharmalot By Ed Silverman

Supreme Court lets pay-to-delay ruling against pharma stand

Pharmalot By Ed Silverman

FTC seeks review of a court ruling on generic drug competition

Pharmalot By Ed Silverman

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

Pharmalot By Ed Silverman

Senator urges FTC to step up investigation into maker of addiction treatment

Pharmalot By Ed Silverman

Drug maker loses appeal of antitrust pay-to-delay case in Europe

Exclusive By Ike Swetlitz and Ed Silverman

Mylan may have violated antitrust law in its EpiPen sales to schools, legal experts say

Pharmalot By Ed Silverman

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pharmalot By Ed Silverman

Most Read

Consumer groups and unions urge FTC to block AbbVie and Allergan merger

Pharmalittle: Opioid settlements may yield tax breaks for drug makers; EMA probes heartburn meds for carcinogens

Drug makers are sued for scheming to illegally fix insulin prices

Supreme Court lets pay-to-delay ruling against pharma stand

Mylan may have violated antitrust law in its EpiPen sales to schools, legal experts say

Generic drug price-fixing suit is akin to earlier case, but ‘on steroids,’ Conn. prosecutor says

FTC seeks review of a court ruling on generic drug competition

Pfizer fined by UK regulator amid pricing probe

All Coverage

Johnson & Johnson is fined $30 million for thwarting generics in France

FTC probes Mylan for possible antitrust violations involving EpiPen

Drug makers are sued for scheming to illegally fix insulin prices

Two former pharma execs first to be charged in generic price-fixing probe

Pharmalot, Pharmalittle: FTC is ‘aware’ of concerns over possible Mylan antitrust violations

Lawmakers call for FTC probe into potential antitrust violations in EpiPen school program

Supreme Court lets pay-to-delay ruling against pharma stand

FTC seeks review of a court ruling on generic drug competition

Drug maker fined for shorting supplies of cancer drugs in order to raise prices

Senator urges FTC to step up investigation into maker of addiction treatment

Drug maker loses appeal of antitrust pay-to-delay case in Europe

Mylan may have violated antitrust law in its EpiPen sales to schools, legal experts say

Glaxo, other drug makers appeal UK fines for pay-to-delay deals

Pfizer fined by UK regulator amid pricing probe